Walleye Capital LLC Clearside Biomedical, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $140,090 - $298,860	-103,771 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$2.72 - $5.72 $282,257 - $593,570	103,771 New	103,771 $285,000
Q3 2021 Nov 15, 2021	SELL	$4.83 - $7.2 $86,940 - $129,600	-18,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $41,760 - $96,840	18,000 New	18,000 $88,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $60.8M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.